Encourages expression of feelings to identify the need for information and support and to dismiss guilt and anxiety
[16] Reported rates from trials include: Nausea: ~44% Vomiting: ~25% Diarrhea: ~31% Constipation: ~23% Dyspepsia: ~10% These effects reflect slowed gastric motility and are usually mild, but can lead to clinical implications: Dehydration Electrolyte abnormalities ED presentations for poor oral intake
It's important to discuss your complete medical history with a health care provider before starting any new medication, including GLP-1 agonists
This guide will mainly focus on the three more-recent long-lasting forms of injectable GLP-1s: Liraglutide (Saxenda) Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro) Should I take GLP-1 drugs
These forms are amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate
Secondary analysis of renal end points in a cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM at high cardiovascular risk, showing that saxagliptin reduces albuminuria in a glucose-independent manner